oncology
Astellas constitutes a reference in the areas of Transplantation, Urology and Anti-infectives, a position we have achieved to extend it to Oncology, thanks to our commitment to innovation.

With approximately 20% of our sales earmarked for research, we aim to build a strong presence in therapeutic areas where a large number of unmet medical needs still exist.

Currently we have 12 different molecules in clinical development phase in Oncology. Through these research programs, we aspire to change the tomorrow of patients suffering from solid tumors such as Prostate Cancer and others in close future, or haematologic malignancies.

 

EN-PL Xtandi Caps
EN-PL Xtandi Tabs
EN-Padcev PAC PIL

Learn more about our therapeutic areas:

Oncology

Through research programs, we aim to change the tomorrow of patients suffering from solid tumours, such as Prostate Cancer, and haematologic malignancies.

Urology

Focused on research to meet the needs in Benign Prostatic Hyperplasia (BPH) and Overactive Bladder Syndrome (OAB).

Transplantation

Innovative therapies for the prevention and treatment of organ rejection

Anti-infectives

We tackle the complex challenges of Fungal and Bacterial Infections

NON_2019_0011_GR

RELATED LINKS

R & D

Research and Development is at the core of everything we do. It not only drives our work today, but it fosters the work we will do tomorrow...

Read More